The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Onconova Therapeutics Inc (ONTX)

Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule product candidates primarily to treat cancer. Co.'s primary product candidate is rigosertib, which is being tested in an intravenous formulation as a single agent, and an oral formulation in combination with azacitidine, in clinical trials for patients with higher-risk myelodysplastic syndromes. Co.'s other product candidates include: briciclib, which is a small molecule targeting an intracellular regulatory protein, Cyclin D1, which is often found at elevated levels in cancer cells; and recilisib, which is being developed for acute radiation syndromes.

Company Name:  Onconova Therapeutics Inc
Website:  www.onconova.com
Sector:  Biotechnology
Number of ETFs Holding ONTX:  2
Total Market Value Held by ETFs:  $2574
Total Market Capitalization:  $10.00M
% of Market Cap. Held by ETFs:  0.03%
April 26, 2018    10:55 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes



Buy (3.33 out of 4)
56th percentile
(ranked higher than approx. 56% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Onconova Therapeutics Inc (ONTX) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2018, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.